Farletuzumab

• Description :

  Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRα) inhibitor. Farletuzumab is a humanized monoclonal antibody with high affinity for FRα. Farletuzumab possesses growth-inhibitory functions on cells overexpressing FRα. Farletuzumab can be used in research of cancer[1].

• Product Name Alternative :

  MORAb-003

• UNSPSC :

  12352203

• Target :

  Antibiotic

• Type :

  Inhibitory Antibodies

• Related Pathways :

  Anti-infection

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/farletuzumab.html

• Purity :

  99.00

• Solubility :

  10 mM in DMSO

• Smiles :

  [Farletuzumab]

• Molecular Weight :

  (145.36 kDa)

• References & Citations :

  [1]Ebel W, et, al. Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha. Cancer Immun. 2007 Mar 9;7:6.

• Shipping Conditions :

  Dry Ice

• Storage Conditions :

  Store at -80°C for 2 years

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  Phase 3

• CAS Number :

  [896723-44-7]